Evidence map›Paper›PMID 33293541›Full record

ArticleScientific reports2020

A framework to assess the impact of number of trials on the amplitude of motor evoked potentials.

Claudia Ammann, Pasqualina Guida, Jaime Caballero-Insaurriaga, José A Pineda-Pardo, Antonio Oliviero, Guglielmo Foffani

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Motor Cortex Disinhibition Correlates with Olfactory Dysfunction in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claudia AmmannHM CINAC, Hospital Universitario HM Puerta del Sur, HM Hospitales, Universidad CEU-San Pablo, Madrid, Spain.
Pasqualina GuidaHM CINAC, Hospital Universitario HM Puerta del Sur, HM Hospitales, Universidad CEU-San Pablo, Madrid, Spain.
Jaime Caballero-InsaurriagaHM CINAC, Hospital Universitario HM Puerta del Sur, HM Hospitales, Universidad CEU-San Pablo, Madrid, Spain.
José A Pineda-PardoHM CINAC, Hospital Universitario HM Puerta del Sur, HM Hospitales, Universidad CEU-San Pablo, Madrid, Spain.
Antonio OlivieroHospital Nacional de Parapléjicos, Toledo, Spain.
Guglielmo FoffaniHM CINAC, Hospital Universitario HM Puerta del Sur, HM Hospitales, Universidad CEU-San Pablo, Madrid, Spain. gfoffani.hmcinac@hmhospitales.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The amplitude of motor evoked potentials (MEPs) elicited by transcranial magnetic stimulation (TMS) is a common yet highly variable measure of corticospinal excitability. The tradeoff between maximizing the number of trials and minimizing experimental time remains a hurdle. It is therefore important to establish how many trials should be used. The aim of this study is not to provide rule-of-thumb answers that may be valid only in specific experimental conditions, but to offer a more general framework to inform the decision about how many trials to use under different experimental conditions. Specifically, we present a set of equations that show how the number of trials affects single-subject MEP amplitude, population MEP amplitude, hypothesis testing and test-retest reliability, depending on the variability within and between subjects. The equations are derived analytically, validated with Monte Carlo simulations, and representatively applied to experimental data. Our findings show that the minimum number of trials for estimating single-subject MEP amplitude largely depends on the experimental conditions and on the error considered acceptable by the experimenter. Conversely, estimating population MEP amplitude and hypothesis testing are markedly more dependent on the number of subjects than on the number of trials. These tools and results help to clarify the impact of the number of trials in the design and reproducibility of past and future experiments.

Indexed as

AlgorithmsClinical Decision-MakingEvoked Potentials, MotorFemaleHumansMaleMonte Carlo MethodMotor CortexReproducibility of ResultsTranscranial Magnetic Stimulation

Identifiers

PMID33293541
PMCPMC7722939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.